The EBITDA overall has gone down since first half so there is a net loss after tax for the year. But they identified ballooning costs in the first half report and say they have now got them under control going into 2023 financial year which is positive. So yes I agree. It is a pragmatic and realistic summary. Hopefully leading to a profitable cash positive financial year in 2023.
- Forums
- ASX - By Stock
- JAN
- Ann: JAN FY22 Trading Update
JAN
janison education group limited
Add to My Watchlist
0.00%
!
14.5¢

Ann: JAN FY22 Trading Update, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
14.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.68M |
Open | High | Low | Value | Volume |
14.5¢ | 14.5¢ | 14.5¢ | $542 | 3.736K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 124726 | 14.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.0¢ | 3927 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 124726 | 0.145 |
4 | 160530 | 0.140 |
4 | 78414 | 0.135 |
2 | 70000 | 0.130 |
1 | 2076 | 0.120 |
Price($) | Vol. | No. |
---|---|---|
0.150 | 3927 | 2 |
0.155 | 20000 | 1 |
0.160 | 69929 | 3 |
0.165 | 58000 | 1 |
0.170 | 66286 | 2 |
Last trade - 15.06pm 01/07/2025 (20 minute delay) ? |
Featured News
JAN (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online